Sort
21,281 grants matching “influenza”
Prospective Studies of Avian Influenza Transmission in Asia
$351,740Gregory Charles Gray · University Of Florida · R01 · FY2010 · AI
RETINA--REVERSED POLARITY IN RPE
$351,716Weill Medical College Of Cornell Univ · R01 · FY2000 · EY
Biosynthetic studies and development of ribomimetic-based anti-infectives
$351,709Taifo Mahmud · Oregon State University · R01 · FY2019 · AI
The Evolutionary and Biological Bases of Host Switching in Viruses
$351,680Colin R. Parrish · Cornell University · R01 · FY2017 · GM
Memory T cell development and survival in T cell responses of older individuals
$351,676Jorg J Goronzy · Palo Alto Veterans Instit For Research · R01 · FY2019 · AI
Memory T cell development and survival in T cell responses of older individuals
$351,676Jorg J Goronzy · Palo Alto Veterans Instit For Research · R01 · FY2020 · AI
MHC and Gamma/Delta T-Cell Recognition
$351,613Yueh-Hsiu Chien · Stanford University · R01 · FY2006 · AI
Impact of aging T cell responses to influenza vaccination
$351,524Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · P01 · FY2016 · AG
Impact of aging T cell responses to influenza vaccination
$351,522Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · P01 · FY2014 · AG
Glycoprotein interactions in paramyxovirus fusion
$351,500Univ Of Massachusetts Med Sch Worcester · R01 · FY2002 · AI
Role of DM in Generation of Immunodominant Epitope(s)
$351,491Scheherazade Sadegh-Nasseri · Johns Hopkins University · R01 · FY2008 · AI
Role of DM in Generation of Immunodominant Epitope(s)
$351,491Scheherazade Sadegh-Nasseri · Johns Hopkins University · R01 · FY2009 · AI
BAYESIAN MODELING AND DATA INTEGRATION IN INFECTIOUS DISEASE PHYLODYNAMICS
$351,488Volodymyr Minin · University Of Washington · R01 · FY2013 · AI
Systems Analysis of Social Pathways of Epidemics to Reduce Health Disparities
$351,445Achla Marathe · Virginia Polytechnic Inst And St Univ · R01 · FY2016 · GM
Emerging Infections Program (EIP)/PPACA: Enhancing Epidemiology and Laboratory Ca
$351,434Melissa Tobin-D'angelo · Georgia State Departmentof Public Health · U01 · FY2010 · CI
NTHi LPS: virulence factor and vaccine candidate
$351,425Richard Goldstein · Boston University Medical Campus · R01 · FY2006 · DC
Development of a Universal Immunotherapeutic for Influenza Viruses
$351,360Frederick Wayne Holtsberg · Integrated Biotherapeutics, Inc. · R44 · FY2022 · AI
Generation and Regulation of Anti-Viral CD4 T Cells with Cytolytic Potential
$351,312Deborah M Brown · University Of Nebraska Lincoln · R56 · FY2013 · AI
Decision Analysis of Otitis Media Vaccination Strategies
$351,289Harvard Pilgrim Health Care, Inc. · R01 · FY2004 · DC
Project 3: Immune Senescence
$351,278Jorg J Goronzy · Emory University · U19 · FY2020 · AI
In Vitro and In Vivo Approach to Artery Wall Inflammation
$351,218Alan M Fogelman · University Of California Los Angeles · P01 · FY2007 · HL
Central role of Caspase-8 in control of host tolerance and resistance mechanisms in pulmonary macrophage populations during severe respiratory infections
$351,214Amanda M Jamieson · Brown University · R01 · FY2025 · HL
Environmental Influences on Epigenetic Immune Programming
$351,191B. Paige Lawrence · University Of Rochester · R01 · FY2012 · ES
New Peptides for the Treatment of Multiple Sclerosis
$351,172Christine Beeton · Baylor College Of Medicine · R01 · FY2013 · NS
Preventing lethal hemorrhagic fever caused by hantaviruses by preserving endothel
$351,045Alan L Mueller · Navigen, Inc. · R01 · FY2012 · AI